McKesson Corporation $MCK Stock Acquired by Chicago Partners Investment Group LLC

Chicago Partners Investment Group LLC increased its stake in shares of McKesson Corporation (NYSE:MCK) by 26.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,506 shares of the company’s stock after purchasing an additional 522 shares during the quarter. Chicago Partners Investment Group LLC’s holdings in McKesson were worth $2,508,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Nvwm LLC boosted its position in shares of McKesson by 933.3% during the 3rd quarter. Nvwm LLC now owns 31 shares of the company’s stock worth $26,000 after acquiring an additional 28 shares in the last quarter. Delos Wealth Advisors LLC acquired a new stake in McKesson during the second quarter worth approximately $27,000. Trellis Wealth Advisors LLC acquired a new stake in McKesson during the third quarter worth approximately $32,000. Clearstead Trust LLC purchased a new position in shares of McKesson in the 2nd quarter valued at $37,000. Finally, GK Wealth Management LLC purchased a new position in shares of McKesson in the 3rd quarter valued at $38,000. 85.07% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at McKesson

In other news, CAO Napoleon B. Rutledge, Jr. sold 111 shares of the firm’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total value of $98,950.95. Following the completion of the sale, the chief accounting officer owned 521 shares in the company, valued at approximately $464,445.45. This trade represents a 17.56% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bradley E. Lerman sold 301 shares of McKesson stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $892.33, for a total transaction of $268,591.33. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 2,462 shares of company stock valued at $2,511,106. 0.06% of the stock is owned by company insiders.

Key Headlines Impacting McKesson

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: McKesson beat fiscal Q2 2027 estimates, reporting adjusted EPS of $11.68 and revenue of about $111 billion, up roughly 7.5% year over year. The company also raised its fiscal 2027 adjusted EPS outlook to $45.60–$46.40, supported by specialty-drug demand, higher prescription volumes and operating gains. MCK Q2 Earnings Beat Estimates on Specialty Growth, Outlook Raised
• Positive Sentiment: Analyst sentiment has strengthened: UBS raised its price target to $1,250 and maintained a Buy rating, while TD Cowen and Leerink Partners lifted targets to $1,200. Separately, Zacks upgraded MCK to Rank #2 (Buy), citing improving earnings prospects. Zacks upgrades McKesson to Buy
• Neutral Sentiment: EVP Francisco Fraga sold 650 shares under a pre-arranged Rule 10b5-1 plan and retained 4,414 shares. The filing does not explain the purpose of this latest sale; an earlier sale was described as covering tax withholding on vested equity awards. SEC filing
• Negative Sentiment: RBC raised its price target but kept a Sector Perform rating and set a $965 target, below the recent share price. That more cautious view may temper enthusiasm after MCK’s strong run. RBC comments on McKesson’s execution

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Mizuho lifted their price target on shares of McKesson from $905.00 to $1,020.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 20th. Bank of America raised their price objective on McKesson from $950.00 to $1,050.00 in a report on Thursday, August 6th. Argus lifted their target price on McKesson from $850.00 to $970.00 and gave the stock a “buy” rating in a research report on Thursday, September 3rd. Citigroup raised their target price on shares of McKesson from $945.00 to $1,000.00 and gave the stock a “buy” rating in a research report on Friday, July 24th. Finally, Weiss Ratings raised shares of McKesson from a “buy (b-)” rating to a “buy (b)” rating in a report on Friday, September 4th. Fifteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, McKesson currently has a consensus rating of “Moderate Buy” and a consensus target price of $1,026.18.

McKesson Stock Down 1.0%

Shares of MCK stock opened at $1,060.79 on Friday. The stock has a market capitalization of $123.68 billion, a PE ratio of 27.28, a price-to-earnings-growth ratio of 1.99 and a beta of 0.27. McKesson Corporation has a 52-week low of $723.68 and a 52-week high of $1,121.50. The stock’s 50-day moving average price is $938.13 and its 200 day moving average price is $868.12.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, November 4th. The company reported $11.68 earnings per share for the quarter, beating the consensus estimate of $10.72 by $0.96. The company had revenue of $110.96 billion for the quarter, compared to the consensus estimate of $109.90 billion. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%. The company’s revenue was up 7.5% on a year-over-year basis. During the same period last year, the business posted $9.86 EPS. Analysts expect that McKesson Corporation will post 45.26 earnings per share for the current fiscal year.

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Tuesday, December 1st will be given a $0.94 dividend. This represents a $3.76 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Tuesday, December 1st. McKesson’s dividend payout ratio (DPR) is 9.67%.

McKesson Profile

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers.

The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care.

Founded in 1833, McKesson serves customers primarily in the United States and Canada.